The impact of dexmedetomidine on postoperative delirium in patients with obstructive sleep apnea after non-cardiac surgery

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100043849

Enrollment

Unknown

Registered

2021-03-04

Start date

2021-03-01

Completion date

Unknown

Last updated

2021-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative delirium

Interventions

1:no dexmedetomidine

2:low dose of dexmedetomidine

3:high dose of dexmedetomidine

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age > 18 years old, regardless of gender; 2. complete informed consent; 3. the ability to understand and complete the research questionnaire; 4. no history of neurocognitive dysfunction; 5. scheduled non-cardiac elective surgery under general anesthesia; 6. ASA 1 ~ 3; 7. the surgery duration is 2 ~ 5 hours.

Exclusion criteria

Exclusion criteria: 1. Neurosurgery; 2. schizophrenia or active psychosis; 3. history of drug or alcohol dependence or abuse in the past three months; 4. dementia or obvious nervous system diseases (such as stroke, epilepsy, intracranial tumor, Parkinson's disease, etc.); 5. heart rate < 50 beats / min, sick sinus syndrome, severe heart block.

Design outcomes

Primary

Measure	Time frame
postoperative delirium;	—

Countries

China

Contacts

Public ContactYi Zou

Department of Anesthesiology, Beijing Friendship Hospital, Capital Medical University

zouyi871123@126.com+86 10-63138780

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026